3-46925534-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001277074.2(CCDC12):āc.166G>Cā(p.Glu56Gln) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000426 in 1,572,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001277074.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC12 | NM_001277074.2 | c.166G>C | p.Glu56Gln | missense_variant, splice_region_variant | 3/7 | ENST00000683445.1 | NP_001264003.1 | |
CCDC12 | NM_144716.6 | c.205G>C | p.Glu69Gln | missense_variant, splice_region_variant | 4/8 | NP_653317.2 | ||
CCDC12 | NR_102269.2 | n.219G>C | splice_region_variant, non_coding_transcript_exon_variant | 3/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC12 | ENST00000683445.1 | c.166G>C | p.Glu56Gln | missense_variant, splice_region_variant | 3/7 | NM_001277074.2 | ENSP00000508011 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152170Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000135 AC: 3AN: 222792Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 119316
GnomAD4 exome AF: 0.0000408 AC: 58AN: 1420674Hom.: 0 Cov.: 30 AF XY: 0.0000385 AC XY: 27AN XY: 700454
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152170Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.205G>C (p.E69Q) alteration is located in exon 3 (coding exon 3) of the CCDC12 gene. This alteration results from a G to C substitution at nucleotide position 205, causing the glutamic acid (E) at amino acid position 69 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at